首页
期刊简介
编 委 会
期刊订阅
百年学会 医星璀璨
名院风范
学科风华
菁英风采
投稿须知
过刊浏览
联系我们
篇名
关键词
作者
作者单位
摘要
关键词
注册本刊作者
作者投稿查稿
专家远程审稿
编辑在线审稿
编务办公专区
主编办公专区
下载文档
《上海医学》审稿费代缴委托书
《上海医学》杂志2025年征订启事
《上海医学》期刊编审系统审稿专家使用手册
工作动态
01-03
《上海医学》杂志2025年度“春蕾杯”论文评比征文通知
03-05
《上海医学》杂志2024年度“春蕾杯”论文评比征文通知
06-14
创新驱动,培育人才—《上海医学》2021年度春蕾计划评审结果揭晓
01-21
《上海医学》期刊影响力指标和学科排名取得显著提升
01-20
《上海医学》恭祝大家新年快乐!
联系方式
发行周期:
月刊
主管单位:
上海市卫生健康委员会
主办单位:
上海市医学会
编辑出版:
《上海医学》编辑部
联系地址:
上海市北京西路1623号
邮编:
200040
电话:
021-62178606
传真:
021-62178606
邮箱:
smasmj@shsma.org.cn
ISSN:
ISSN0253-9934
CN:
CN31-1366/R
收款账号:
1001255309008900719
账户名:
上海市医学会
开户行:
工商银行上海市静安寺支行
友情链接
上海市医学会
当前位置:首页 >
过刊浏览
->
2011年第12期
加巴喷丁预给药对全麻后导尿病人膀胱刺激症的影响
Influence of Gabapendin premedication on patients with urinary catheter before general anesthesia
浏览(3070) 下载(0)
DOI:
作者:
杨小虎,林福清,付舒昆
YANG Xiao-hu LIN Fu-qing,FU Shu-kun
作者单位:
同济大学附属上海第十人民医院麻醉科
Department of Aneasthesiology ,Tongji university of tenth people’s hospital,Shanghai
关键词:
加巴喷丁;膀胱刺激症;全身麻醉;导尿
摘要:
目的:研究加巴喷丁预给药对全麻后导尿病人的膀胱刺激症的影响。方法:择期全麻下行开腹全子宫切除手术的病人80例,ASAI~II级,随机分为加巴喷丁组和对照组。加巴喷丁组在麻醉诱导前1小时给予口服加巴喷丁600mg,对照组术前未给药。所有的病人都于手术结束后插置16号 Foley导尿管,球囊充1O ml生理盐水,用胶布固定在耻骨弓上区域,并且没有任何牵引。观察并记录入麻醉恢复室即刻(0h)、1h、2h、6h病人膀胱刺激症(CRBD )的发生情况及严重程度。结果:麻醉术后,加巴喷丁组患者的CRBD发生率低于对照组(P<0.05);加巴喷丁组CRBD严重程度也低于对照组。结论:麻醉术前1h口服加巴喷丁600mg可以减少CRBD的发生率及严重程度。
Objective :To study the effect of Gabapendin premedication on patients with urinary catherter after general anesthesia.Methods :80 physical status I and II patients,undergonging elective open abdomen entire hysterectomy requiring catheterization of the urinary bladder, wererandomized with the help of a computer-generated table of random numbers into two equal groups. Group G (gabapentin): received gabapentin 600 mg one hour before anesthesia whereas group C (control): received matching placebo.Urinary bladder catheterization was done with a 16F Foley catheter, and its balloon was inflated with 10 mL distilled water. Thereafter, the catheter was fixed in the suprapubic region with adhesive tape without traction. Bladder discomfort was assessed on arrival in the PACU (0 h) and again at 1, 2, and 6 h postoperatively by an anesthesia registrar who was unaware of the type of medication received by the patient. Results: Gabapentin reduced the incidence of CRBD to 50% (27 of 54) compared with 80% (43 of 54) observed in the control group (P < 0.05). Gabapentin also reduced the severity of CRBD and postoperative pain as observed by a reduction in the number of patients requiring any fentanyl and the total fentanyl consumption postoperatively (P < 0.05). Conclusion Gabapentin (600 mg) administered orally 1 h before surgery reduced the incidence and severity of CRBD, postoperative pain, number of patients requiring fentanyl and postoperative total fentanyl requirement.